Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juerg Schwaller

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Life (Basel, Switzerland)|September 28, 2021
NSD1: A Lysine Methyltransferase between Developmental Disorders and CancerSamantha Tauchmann, Juerg Schwaller
Haematologica|August 16, 2023
First mouse model of infant acute myeloid leukemia with t(7;12)(q36;p17)Zivojin Jevtic, Juerg Schwaller
Hemasphere|April 1, 2024
From hypoxia single-cell gene signatures to HIF targeting of AML leukemic stem cellsThomas Mercher, Juerg Schwaller
Current Opinion in Hematology|December 17, 2002
Role of constitutively activated protein tyrosine kinases in malignant myeloproliferative disorders: an updateEma Anastasiadou, Juerg Schwaller
Haematologica|June 5, 2013
Trithorax and polycomb cooperation in MLL fusion acute leukemiaHelene Méreau, Juerg Schwaller
The Journal of Experimental Medicine|March 21, 2019
Dual roles of <i>EZH2</i> in acute myeloid leukemiaRadek C Skoda, Juerg Schwaller
Swiss Medical Weekly|September 21, 2010
Insights into molecular pathways for targeted therapeutics in acute leukemiaVaia Stavropoulou, Laurent Brault, Juerg Schwaller
Haematologica|June 22, 2014
Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia inductionAngeliki Thanasopoulou, Alexandar Tzankov, Juerg Schwaller
Molecular & Cellular Oncology|November 25, 2020
NSD1 in erythroid differentiation and leukemogenesisSamantha Tauchmann, Marwa Almosailleakh, Juerg Schwaller
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|December 15, 2010
Epigenetic mechanisms in acute myeloid leukemiaAntoine H F M Peters, Juerg Schwaller
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Life (Basel, Switzerland)|September 28, 2021
NSD1: A Lysine Methyltransferase between Developmental Disorders and CancerSamantha Tauchmann, Juerg Schwaller
Haematologica|August 16, 2023
First mouse model of infant acute myeloid leukemia with t(7;12)(q36;p17)Zivojin Jevtic, Juerg Schwaller
Hemasphere|April 1, 2024
From hypoxia single-cell gene signatures to HIF targeting of AML leukemic stem cellsThomas Mercher, Juerg Schwaller
Current Opinion in Hematology|December 17, 2002
Role of constitutively activated protein tyrosine kinases in malignant myeloproliferative disorders: an updateEma Anastasiadou, Juerg Schwaller
Haematologica|June 5, 2013
Trithorax and polycomb cooperation in MLL fusion acute leukemiaHelene Méreau, Juerg Schwaller
The Journal of Experimental Medicine|March 21, 2019
Dual roles of <i>EZH2</i> in acute myeloid leukemiaRadek C Skoda, Juerg Schwaller
Swiss Medical Weekly|September 21, 2010
Insights into molecular pathways for targeted therapeutics in acute leukemiaVaia Stavropoulou, Laurent Brault, Juerg Schwaller
Haematologica|June 22, 2014
Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia inductionAngeliki Thanasopoulou, Alexandar Tzankov, Juerg Schwaller
Molecular & Cellular Oncology|November 25, 2020
NSD1 in erythroid differentiation and leukemogenesisSamantha Tauchmann, Marwa Almosailleakh, Juerg Schwaller
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|December 15, 2010
Epigenetic mechanisms in acute myeloid leukemiaAntoine H F M Peters, Juerg Schwaller
Pageof 7